Advertisement
U.S. Markets closed

Avivagen Inc. (VIVXF)

OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
0.0001-0.0036 (-97.30%)
At close: 04:00PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in CAD. All numbers in thousands
Breakdown
ttm
10/31/2022
10/31/2021
10/31/2020
10/31/2019
Total Revenue
939.173
939.173
1,296
1,178
977.451
Cost of Revenue
538.874
538.874
761.651
706.877
450.97
Gross Profit
400.299
400.299
534.34
470.98
526.481
Operating Expense
1,934
1,934
1,892
3,858
4,419
Operating Income
-1,534
-1,534
-1,358
-3,387
-3,893
Net Non Operating Interest Income Expense
-1,168
-1,168
-2,247
-1,337
-893.511
Other Income Expense
-3,364
-3,364
-2,790
-27.277
-50
Pretax Income
-6,066
-6,066
-6,394
-4,751
-4,836
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-6,066
-6,066
-6,394
-4,751
-4,836
Diluted NI Available to Com Stockholders
-6,066
-6,066
-6,394
-4,751
-4,836
Basic EPS
-0.06
-0.09
-0.12
-0.12
-0.14
Diluted EPS
-0.06
-0.09
-0.12
-0.12
-0.14
Basic Average Shares
69,374
66,028
52,444
40,308
34,364
Diluted Average Shares
69,374
66,028
52,444
40,308
34,364
Total Expenses
2,473
2,473
2,654
4,565
4,870
Net Income from Continuing & Discontinued Operation
-6,066
-6,066
-6,394
-4,751
-4,836
Normalized Income
-2,702
-2,702
-3,644
-4,751
-4,836
Interest Income
0.68
0.68
4.691
9.007
0
Interest Expense
1,769
1,769
1,586
1,215
925.856
Net Interest Income
-1,168
-1,168
-2,247
-1,337
-893.511
EBIT
-4,298
-4,298
-4,808
-3,536
-3,911
EBITDA
-4,210
-4,210
-4,683
-3,409
-3,906
Reconciled Cost of Revenue
538.874
538.874
761.651
706.877
450.97
Reconciled Depreciation
87.499
87.499
124.774
127.493
4.636
Net Income from Continuing Operation Net Minority Interest
-6,066
-6,066
-6,394
-4,751
-4,836
Total Unusual Items Excluding Goodwill
-3,364
-3,364
-2,750
-
-
Total Unusual Items
-3,364
-3,364
-2,750
-
-
Normalized EBITDA
-846.031
-846.031
-1,933
-3,409
-3,906
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0